Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-21

Clinical Trial Update: The Significance of Urine UbA52 In the Diagnosis of Diabetic Nephropathy

View source ↗

Summary

Completed clinical trial assessing urine UbA52 as a diagnostic biomarker for diabetic nephropathy. The study was sponsored by Hebei Medical University Third Hos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hebei Medical University Third Hospital | Conditions: Diabetic Nephropathy | Status: COMPLETED